V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213271 | 20154826 | 1.62 | 38.4 | Palliative (P) | 2019-06-30 | 2019-08-05 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100602605 |
| 20213274 | 20154827 | 1.93 | 92 | Palliative (P) | 2019-05-11 | 2019-06-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101335277 |
| 20213276 | 20154828 | 1.79 | 93 | Palliative (P) | 2018-02-02 | 2018-02-23 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100719364 |
| 20213284 | 20154829 | 1.86 | 93 | Palliative (P) | 2020-01-16 | 2020-04-19 | GEMCITABINE + NAB PACLITAXEL | N | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101108826 |
| 20213289 | 20154830 | 1.65 | 90.3 | Palliative (P) | 2019-01-19 | 2019-02-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100994229 |
| 20213298 | 20154831 | 1.74 | 79 | Palliative (P) | 2020-02-29 | 2020-03-21 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101746436 |
| 20213303 | 20154832 | 1.72 | 47 | null | null | 2018-12-26 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100475204 |
| 20213305 | 20154833 | 1.6 | 66 | Palliative (P) | 2016-07-11 | 2017-01-01 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100266986 |
| 20213308 | 20154834 | 1.84 | 84.2 | Palliative (P) | 2021-04-22 | 2021-05-04 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100286853 |
| 20213312 | 20154835 | 1.71 | 60 | Palliative (P) | 2016-11-29 | 2016-12-04 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100637707 |
| 20213313 | 20154836 | 1.47 | 54.9 | Palliative (P) | 2019-05-14 | 2019-08-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101352390 |
| 20213316 | 20154837 | 1.74 | 71.3 | Palliative (P) | 2018-08-14 | 2018-08-14 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100094673 |
| 20213317 | 20154838 | 1.88 | 71 | null | 2019-08-24 | 2019-09-09 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101512520 |
| 20213320 | 20154839 | 1.76 | 72 | Palliative (P) | 2018-08-31 | 2019-04-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101384205 |
| 20213321 | 20154840 | 1.71 | 90.2 | Palliative (P) | 2019-09-22 | 2019-09-22 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101242335 |
| 20213323 | 20154841 | 1.85 | 73.7 | Palliative (P) | 2019-04-08 | 2019-04-08 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101170129 |
| 20213327 | 20154842 | 1.73 | 71.2 | null | 2018-02-20 | 2018-02-20 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101521341 |
| 20213329 | 20154843 | 1.82 | 89 | Palliative (P) | 2019-07-27 | 2019-11-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101809902 |
| 20213338 | 20154844 | 1.74 | 70.4 | Palliative (P) | 2021-05-29 | 2021-06-17 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101271803 |
| 20213339 | 20154845 | 1.82 | 108 | Palliative (P) | 2019-03-23 | 2019-03-30 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100417653 |
| 20213340 | 20154846 | null | 85 | Palliative (P) | 2020-07-24 | 2020-09-08 | HCX (Cape + Cisp + Tras) - Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100480454 |
| 20213344 | 20154847 | 1.72 | 68 | null | 2017-06-05 | 2017-06-17 | HCX | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100499929 |
| 20213346 | 20154848 | 1.74 | 92.8 | null | 2019-06-04 | 2019-06-18 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101318273 |
| 20213347 | 20154849 | null | 47 | Adjuvant (A) | 2020-06-12 | 2020-07-01 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100372960 |
| 20213349 | 20154850 | 1.6 | 80.2 | Adjuvant (A) | 2020-01-10 | 2020-06-21 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101740453 |
| 20213351 | 20154851 | 1.57 | 41.1 | Palliative (P) | 2017-10-17 | 2017-10-17 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101117856 |
| 20213356 | 20154852 | 1.55 | 57.65 | Curative (C) | 2021-04-23 | 2021-05-08 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100940057 |
| 20213359 | 20154853 | 1.73 | 54.9 | Neo-adjuvant (N) | 2021-01-19 | 2021-01-20 | ECX | null | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100616159 |
| 20213363 | 20154854 | 1.63 | 56.2 | Neo-adjuvant (N) | 2018-09-28 | 2018-09-28 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101627681 |
| 20213365 | 20154855 | 1.8 | 67 | null | 2019-10-02 | 2019-11-13 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100959385 |
| 20213370 | 20154856 | 1.73 | 57 | Palliative (P) | 2019-12-02 | 2020-03-22 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101854536 |
| 20213371 | 20154857 | 1.74 | 64.8 | null | 2018-10-27 | 2019-04-01 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100859083 |
| 20213373 | 20154858 | 1.74 | 54.9 | Palliative (P) | 2018-06-12 | 2018-07-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100234632 |
| 20213375 | 20154859 | 1.6 | 43.5 | Neo-adjuvant (N) | 2019-01-21 | 2019-01-27 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100790360 |
| 20213377 | 20154860 | 1.81 | 67.7 | Palliative (P) | 2020-05-07 | 2020-05-15 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100973097 |
| 20213381 | 20154861 | 1.82 | 70 | Palliative (P) | 2021-11-04 | 2021-11-13 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100749206 |
| 20213383 | 20154862 | 1.72 | 67.3 | Palliative (P) | 2022-02-26 | 2022-03-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101808647 |
| 20213387 | 20154863 | 1.7 | 62.9 | null | 2021-11-09 | 2021-11-19 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CAPECITABINE + CARBOPLATIN | 101168547 |
| 20213390 | 20154864 | null | null | 03 | 2018-09-02 | 2018-09-05 | null | N | N | ECX | 100070068 |
| 20213393 | 20154865 | 1.6 | 96.6 | null | 2017-12-30 | 2018-01-01 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101611575 |
| 20213398 | 20154867 | 1.73 | 75 | 03 | 2017-04-19 | 2017-04-24 | null | N | N | ECX | 100769443 |
| 20213399 | 20154868 | 1.7 | 90.3 | null | null | 2020-12-02 | Panitumumab | 02 | null | PANITUMUMAB | 101834300 |
| 20213402 | 20154869 | null | 59.6 | null | 2019-06-28 | 2019-07-18 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 101523000 |
| 20213414 | 20154870 | 1.78 | 73.6 | Neo-adjuvant (N) | 2021-01-15 | 2021-11-21 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100282934 |
| 20213415 | 20154871 | null | 66.7 | Palliative (P) | 2020-10-18 | 2020-11-05 | Panitumumab | N | N | PANITUMUMAB | 100182408 |
| 20213426 | 20154873 | null | null | Palliative (P) | null | 2019-02-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100267610 |
| 20213429 | 20154874 | null | null | null | 2019-05-31 | 2019-06-26 | ECX | 02 | null | CARBOPLATIN + ETOPOSIDE | 100219550 |
| 20213430 | 20154875 | 1.7 | null | Palliative (P) | 2021-01-09 | 2021-01-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101724154 |
| 20213434 | 20154876 | 1.67 | 104.2 | null | 2020-06-15 | 2020-06-21 | ECX | 02 | null | ECX | 100998505 |
| 20213439 | 20154877 | null | null | null | 2019-03-03 | 2019-03-03 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100772635 |